WallStreetZenWallStreetZen

NASDAQ: INBX
Inhibrx Biosciences Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for INBX

Based on 2 analysts offering 12 month price targets for Inhibrx Biosciences Inc

Min Forecast
$150.00+37.27%
Avg Forecast
$197.50+80.74%
Max Forecast
$245.00+124.22%

Should I buy or sell INBX stock?

Based on 2 analysts offering ratings for Inhibrx Biosciences Inc.

Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although INBX's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates INBX as a "Strong Sell". Stocks with a Zen Rating of Strong Sell have had an average return of -12.86% per year. Learn More

Be the first to know when Wall Street analysts revise their INBX stock forecasts and price targets.

INBX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-08-24
lockedlocked$00.00+00.00%2026-04-08

1 of 1

Forecast return on equity

Is INBX forecast to generate an efficient return?

Company
-6.23%
Industry
20.5%
Market
167.71%
INBX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is INBX forecast to generate an efficient return on assets?

Company
2.14%
Industry
23.66%
INBX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

INBX earnings per share forecast

What is INBX's earnings per share in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$10.44
Avg 2 year Forecast
-$9.82
Avg 3 year Forecast
-$6.00

INBX revenue forecast

What is INBX's revenue in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
$0.0
Avg 2 year Forecast
$58.3M
Avg 3 year Forecast
$168.4M

INBX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
INBX$109.27$197.50+80.74%Strong Buy
SNDX$18.18$37.86+108.23%Strong Buy
TSHA$5.02$12.78+154.54%Strong Buy
FTRE$17.20$22.00+27.91%Strong Buy
NTLA$11.74$21.27+81.20%Hold
View Top Biotech Stocks

Inhibrx Biosciences Stock Forecast FAQ

Is Inhibrx Biosciences Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: INBX) stock is to Strong Buy INBX stock.

Out of 2 analysts, 1 (50%) are recommending INBX as a Strong Buy, 1 (50%) are recommending INBX as a Buy, 0 (0%) are recommending INBX as a Hold, 0 (0%) are recommending INBX as a Sell, and 0 (0%) are recommending INBX as a Strong Sell.

If you're new to stock investing, here's how to buy Inhibrx Biosciences stock.

What is INBX's earnings growth forecast for 2026-2028?

(NASDAQ: INBX) Inhibrx Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.23%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 30.8%.

Inhibrx Biosciences's earnings in 2026 is -$138,181,000.On average, 4 Wall Street analysts forecast INBX's earnings for 2026 to be -$153,594,972, with the lowest INBX earnings forecast at -$156,925,578, and the highest INBX earnings forecast at -$148,092,038. On average, 4 Wall Street analysts forecast INBX's earnings for 2027 to be -$144,505,345, with the lowest INBX earnings forecast at -$147,117,729, and the highest INBX earnings forecast at -$139,885,471.

In 2028, INBX is forecast to generate -$88,316,262 in earnings, with the lowest earnings forecast at -$95,049,592 and the highest earnings forecast at -$79,987,539.

What is INBX's revenue growth forecast for 2026-2028?

(NASDAQ: INBX) Inhibrx Biosciences's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 32.79%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.22%.

Inhibrx Biosciences's revenue in 2026 is $0.On average, 4 Wall Street analysts forecast INBX's revenue for 2026 to be $0, with the lowest INBX revenue forecast at $0, and the highest INBX revenue forecast at $0. On average, 4 Wall Street analysts forecast INBX's revenue for 2027 to be $858,319,214, with the lowest INBX revenue forecast at $779,579,733, and the highest INBX revenue forecast at $931,848,643.

In 2028, INBX is forecast to generate $2,477,718,061 in revenue, with the lowest revenue forecast at $2,380,581,505 and the highest revenue forecast at $2,550,570,478.

What is INBX's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: INBX) forecast ROA is 2.14%, which is lower than the forecast US Biotechnology industry average of 23.66%.

What is INBX's Price Target?

According to 2 Wall Street analysts that have issued a 1 year INBX price target, the average INBX price target is $197.50, with the highest INBX stock price forecast at $245.00 and the lowest INBX stock price forecast at $150.00.

On average, Wall Street analysts predict that Inhibrx Biosciences's share price could reach $197.50 by Aug 24, 2027. The average Inhibrx Biosciences stock price prediction forecasts a potential upside of 80.74% from the current INBX share price of $109.27.

What is INBX's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: INBX) Inhibrx Biosciences's current Earnings Per Share (EPS) is -$8.88. On average, analysts forecast that INBX's EPS will be -$10.44 for 2026, with the lowest EPS forecast at -$10.66, and the highest EPS forecast at -$10.06. On average, analysts forecast that INBX's EPS will be -$9.82 for 2027, with the lowest EPS forecast at -$10.00, and the highest EPS forecast at -$9.50. In 2028, INBX's EPS is forecast to hit -$6.00 (min: -$6.46, max: -$5.43).

What is INBX's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: INBX) forecast ROE is -6.23%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.